1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Drivers for Healthcare R&D Investment in Asia-Pacific : Rise of the APAC R&D Giants

Introduction

Investment in Research and Development (R&D) is the key to sustaining innovation and promoting growth in the healthcare industry. This report broadly tracks the events and crucial reasons that have transformed the APAC region into a preferred R&D investment destination. We highlight four countries—China, Singapore, South Korea, and Taiwan—which showed the highest increase in R&D investment between 2009 and 2012. Driven by healthcare market growth in the region, these countries have emerged as hotspots for R&D investment as a result of improved Intellectual Property (IP) regimes, governments’ promotions and incentives, and increased research capabilities.

Executive Summary

For over a decade, investments in R&D have been waning in Western countries and steadily making their way into the APAC region. A large number of companies have set up R&D bases in Asian countries either to specifically cater to the local markets or to develop products that withstand market dynamics in both developed and emerging markets.
Riding the wave of growth in Asia, multinational companies such as Merck (US) established its Asia R&D headquarters in Wangjing Park, one of Beijing's rapidly expanding science and technology parks in 2011. In Singapore, attractive government co-investments have encouraged companies like GSK and Lonza to build substantial production capabilities in the country. Likewise, the Taiwanese government has recognized the importance of supporting the biotechnology industry in recent years and has created new initiatives such as the National Development Fund under the Executive Yuan. These efforts have prompted companies including Progen Pharmaceuticals (Australia) to tie up with local manufacturers such as Medigen Biotechnology Corp for their R&D activities to develop the PI-88 anti-cancer drug.
The shift in R&D investments is attributed to favourable government policies and regulations in Asian countries that collectively create an environment conducive for innovation. However, not all countries are as appealing when it comes to R&D spending. Within the APAC region, R&D investments appear to be moving from traditional to emerging R&D hotspots, with Australia standing out as an example of a conventional market struggling to retain R&D investments in the past few years.
Many APAC markets are competing as viable alternatives for cost-effective R&D and providing attractive commercialization opportunities. Countries that do not have the comfort of a large market size like China will need to enhance areas within their control, such as regulatory and tax environments, in order to continue drawing in funds for R&D.

Asia: An Emerging R&D Hub

Innovation in any industry, let alone healthcare, is improbable without investments in R&D. A minimum threshold of R&D is expected to drive healthy innovation across companies, countries, and regions. Not only does R&D investment fuel the development and growth of new products and technologies, but it also sparks curiosity, enthusiasm, and essential characteristics for a progressive and productive workforce. R&D expenditure is considered to be an essential criterion that reflects national development. It is influenced by a number of factors including political climate, fiscal policies, resource availability, and regulatory regimes.

Globally, there has been a decline in R&D spending, including in the healthcare industry. Even though healthcare has been more resilient on this front when compared with other industries, this trend is expected to reverse with the growing need for improvements in cost and quality of care across almost all countries and regions in the next few years. Between 2007 and 2012, total investment in healthcare R&D increased at a compound annual growth rate (CAGR) of only x %. The significant drop in global healthcare R&D spending in 2009 was a result of the recession as well as cuts in healthcare expenditure across developed markets, as a part of austerity measures.

Table Of Contents

Drivers for Healthcare RandD Investment in Asia-Pacific : Rise of the APAC RandD Giants
Introduction 3
Executive Summary 3
Asia: An Emerging RandD Hub 4
Drivers for Increasing RandD Investment in APAC 6
Conclusion 9
References 10
Legal Disclaimer 11
The Frost and Sullivan Story 12

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2016

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2016

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the collaborative R&D deals ...

Top 20 Companies Developing Autonomous Vehicles (AV) Technologies 2016

Top 20 Companies Developing Autonomous Vehicles (AV) Technologies 2016

  • $ 2257
  • Industry report
  • August 2016
  • by Visiongain

Report Details This revolutionary report from market intelligence provider visiongain offers comprehensive insight into the top 20 companies developing autonomous vehicles in 2016. Benefits of This Report ...

Scientific Research and Development (R&D) in Physics, Engineering, Telecommunications and Computers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts: NAIC 541712

Scientific Research and Development (R&D) in Physics, Engineering, Telecommunications and Computers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts: NAIC 541712

  • $ 1995
  • Industry report
  • November 2016
  • by Plunkett Research

Scientific Research and Development (R&D) in Physics, Engineering, Telecommunications and Computers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2023, NAIC ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.